
·
16 min
Sanofi: The €130B Pharma Reinvention — How Dupixent and mRNA Are Reshaping Europe's Largest Drugmaker
Inside Sanofi's radical transformation from diversified pharmaceutical conglomerate to focused immunology and mRNA powerhouse, with €50B+ in pipeline value.

